Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637582 · ClinicalTrials.gov registry record · NA
Contribution of Urethral Sensory Feedback in Voiding Efficiency
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03637582: Completed NA study, sponsored by Duke University.
NCT03637582 is a NA study that has completed, run by Duke University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637582, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how urethral anesthesia impacts voiding efficiency in healthy women. The investigator hypothesizes that anesthetizing the urethral with lidocaine gel will decrease voiding efficiency as measured by standard bladder testing (urodynamic testing).
Primary Outcome
voided volume/{voided volume + residual volume} during micturition study during urodynamic studies
Interventions
- DRUG lidocaine gel
- OTHER Plain aqueous gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2018-12-21 |
| Phase | NA |
What the finished NCT03637582 record still lists
NCT03637582 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which lidocaine gel is the first listed.
NCT03637582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03637582 about?
NCT03637582 is a clinical study titled "Contribution of Urethral Sensory Feedback in Voiding Efficiency". The purpose of this study is to evaluate how urethral anesthesia impacts voiding efficiency in healthy women. The investigator hypothesizes that anesthetizing the urethral with lidocaine gel will decrease voiding efficiency as measured by standard bladder testing (urodynamic testing).
What is the current status of trial NCT03637582?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-11-26. Estimated completion is 2018-12-21.
What interventions are being tested in trial NCT03637582?
The interventions under investigation include: lidocaine gel (DRUG), Plain aqueous gel (OTHER).
Who is sponsoring clinical trial NCT03637582?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03637582's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI